Abbvie Stock News

Firm pulls back holdings in Chinese companies Check out Tweedy Browne Stock Picks » Download GuruFolio Report of Tweedy Browne (Updated on 11/28/2021) Related Stocks: BABA , BIDU , GOOG , FMC , ABBV , BRK.A , GOOGL , JNJ , CSCO ,

Autus Asset Management LLC boosted its stake in AbbVie Inc. (NYSE:ABBV) by 2.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96,568 shares of the company’s stock after buying an additional 2,516 shares during the quarter. Autus Asset Management […]

Symmetry Partners LLC trimmed its position in shares of AbbVie Inc. (NYSE:ABBV) by 2.7% during the third quarter, HoldingsChannel reports. The firm owned 28,458 shares of the companys stock after selling 800 shares during the quarter. Symmetry Partners LLCs holdings in AbbVie were worth $3,116,000 at the end of the most recent quarter. Other institutional []

Nisa Investment Advisors LLC lowered its position in AbbVie Inc. (NYSE:ABBV) by 6.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 493,794 shares of the companys stock after selling 32,468 shares during the quarter. Nisa Investment Advisors LLCs holdings in []

Moser Wealth Advisors LLC lifted its stake in shares of AbbVie Inc. (NYSE:ABBV) by 1.5% in the third quarter, HoldingsChannel reports. The fund owned 13,786 shares of the company’s stock after acquiring an additional 200 shares during the period. AbbVie makes up approximately 1.0% of Moser Wealth Advisors LLC’s holdings, making the stock its 26th […]

AdvisorNet Financial Inc decreased its position in shares of AbbVie Inc. (NYSE:ABBV) by 9.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,272 shares of the company’s stock after selling 3,990 shares during the period. AdvisorNet Financial Inc’s […]

A recent analytical report on the Global "Dermatology Drug Market" offers a full recap and comprehensive description of the business and also offers sophisticated knowledge about the key market players and key factors that will influence the business growth. The

Global Breast Reconstruction Market Synopsis: According to the world class Breast Reconstruction Market report, the leading players are focusing more on offering products at rational prices to gain a competitive advantage over the other players in the Healthcare industry. The main

Bangor Savings Bank boosted its stake in shares of AbbVie Inc. (NYSE:ABBV) by 29.1% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 15,240 shares of the companys stock after buying an additional 3,437 shares during the period. Bangor Savings Banks holdings in AbbVie were worth $1,644,000 at the end of the most recent reporting []

Pancreatitis Drugs Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The report answers questions on the current and future technological advancements and development. It delivers an analysis of main manufactures and geographic regions.

Tandem Investment Advisors Inc. lifted its position in AbbVie Inc. (NYSE:ABBV) by 6.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 495,605 shares of the companys stock after purchasing an additional 32,177 shares during the quarter. AbbVie accounts for approximately 4.4% of Tandem Investment []

Sheets Smith Wealth Management lowered its stake in shares of AbbVie Inc. (NYSE:ABBV) by 0.8% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 19,646 shares of the companys stock after selling 159 shares during the period. Sheets Smith Wealth Managements holdings in AbbVie were worth $2,119,000 []

Sumitomo Mitsui DS Asset Management Company Ltd decreased its stake in shares of AbbVie Inc. (NYSE:ABBV) by 0.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 136,963 shares of the companys stock after selling 1,201 shares during the quarter. Sumitomo Mitsui DS []

Livingston Group Asset Management CO operating as Southport Capital Management decreased its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 82.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,531 shares of the companys stock after selling 11,566 shares during the []